Coconut Oil Narikela Taila

Names and identification

Language	Name
English	Coconut Oil Narikela Taila

Key Phytochemical Constituents

• Medium-chain triglycerides (MCTs): 60-65% total fat
• Lauric acid (C12:0) - 47-52% (primary MCT)
• Capric acid (C10:0) - 6-7%
• Caprylic acid (C8:0) - 7-8%
• Myristic acid (C14:0) - 16-18%
• Oleic acid (C18:1) - 5-8%
• Polyphenols (in virgin coconut oil): ferulic acid, p-coumaric acid
• Tocopherols and tocotrienols (vitamin E)
• Phytosterols: beta-sitosterol, stigmasterol
• Monolaurin (derived from lauric acid in vivo)

How does it work?

• Antimicrobial: Lauric acid and its monoglyceride monolaurin disrupt lipid bilayer cell membranes of bacteria, fungi, and enveloped viruses; broad-spectrum activity confirmed against Gram-positive and Gram-negative pathogens
• MCT-mediated energy and cognition: Medium-chain fatty acids bypass normal fat digestion, are rapidly absorbed and converted to ketone bodies in the liver, providing alternative brain fuel; relevant for Alzheimer’s and neurodegeneration
• Cooling and Pitta-pacifying: Sweet taste and cooling virya make it the ideal oil for Pitta constitution and hot-climate Abhyanga; reduces inflammatory heat in skin conditions
• Skin barrier repair: Saturated fatty acid composition closely mimics skin lipid profile; enhances stratum corneum integrity, reduces transepidermal water loss, and provides occlusive moisturization

Which traditional uses are supported by research?

• Kesha (hair health) and Khalitya (hair loss): Lauric acid’s affinity for hair protein reduces protein loss during washing; antimicrobial action against dandruff-causing Malassezia fungi validated by scalp microbiome studies
• Daha and Pitta disorders (burning/inflammatory conditions): Cooling virya combined with anti-inflammatory polyphenols and skin barrier repair validate extensive Ayurvedic use in Pitta skin conditions and Abhyanga
• Kavala/Gandusha (oil pulling): 2025 RCT validates traditional oil pulling with coconut oil for reducing periodontal pathogens and oral inflammation

What do recent clinical trials show?

• Pardiñas López S, García-Caro ME, Vallejo JA and others 2025. Anti-inflammatory and antimicrobial efficacy of coconut oil for periodontal pathogens: a triple-blind randomized clinical trial. Clinical oral investigations. PMID 40085302 · doi:10.1007/s00784-025-06267-8
  Triple-blind RCT confirmed virgin coconut oil (47.92% lauric acid) demonstrated significant antimicrobial efficacy against periodontal pathogens and anti-inflammatory benefits in oral health.
• M A, I MA, Ramalingam K and others 2024. Biomedical Applications of Lauric Acid: A Narrative Review. Cureus. PMID 39036266 · doi:10.7759/cureus.62770
  Lauric acid disrupts bacterial, fungal, and viral cell membranes, leading to pathogen death; monolaurin (derived from lauric acid) has broad-spectrum antimicrobial activity including against MRSA, Helicobacter pylori, and Candida albicans.

1 further claim previously listed here could not be traced to a published paper and has been removed. Classical formulations are researched largely in journals that PubMed does not index, so an absence here reflects the reach of the index rather than the state of the evidence.

Recent safety updates

• High saturated fat content (82-92%) raises LDL cholesterol in some individuals; AHA advises against excessive dietary coconut oil consumption for cardiovascular risk
• Extra virgin coconut oil (cold-pressed) retains polyphenols; refined coconut oil loses most bioactive compounds and may contain processing residues
• Comedogenic rating of 4/5; may cause or worsen acne in facial application for acne-prone individuals despite antimicrobial properties
• MCT overconsumption can cause diarrhea, nausea, and GI distress; gradual introduction recommended for dietary supplementation

What is it made of?

Key Active Markers

• Polyphenols
• Coconut Oil
• Tocopherols
• Phytosterols
• Sitosterol
• Stigmasterol
• Medium-chain triglycerides
• Lauric acid

Analytical Methods: HPLC fingerprinting, TLC (identity), LC-MS/MS (marker quantification)

Dosage forms and preparation

Dosage Forms: Taila (base oil for external/internal use), Capsules (modern), Topical preparations

Standard Dosage: 5-15 mL orally; externally as required for Abhyanga, Shirodhara, and as base oil, as per AFI/classical texts

Bioavailability: Rich in medium-chain triglycerides (MCTs) — lauric acid is rapidly absorbed and converted to monolaurin in the body. MCTs bypass normal lipid absorption pathway, going directly to liver via portal vein for rapid energy. Superior carrier oil for transdermal delivery of lipophilic drugs.

Optimal Timing: External: morning before bath. Internal: morning on empty stomach or as prescribed.

Shelf Life: 2 years (virgin cold-pressed), 3 years (refined) from date of manufacture

Storage: Store in airtight glass or food-grade containers. Solidifies below 24°C (normal). Temperature not exceeding 30°C for liquid state. Stable oil — less prone to oxidative rancidity than polyunsaturated oils.

Marker Compounds: Lauric acid, Myristic acid, Capric acid, Caprylic acid, Tocopherols, Polyphenols (in virgin oil)

Quality Parameters: Acid value (<3 for virgin), peroxide value (<5), saponification value (248-265), iodine value (7-12), refractive index (1.448-1.450 at 40°C), specific gravity (0.915-0.920 at 30°C), moisture (<0.25%), lauric acid content (44-52% by GC), medium-chain triglyceride content, rancidity test negative, microbial limits, pesticide residues

Vehicle (Anupana): Not applicable for external use. Internal: taken directly or with warm water.

Synergistic Combinations

• Sesame oil (in Ayurvedic oil blends)
• Herbs processed in coconut oil for Keraliya preparations
• Kshirabala Thailam
• Eladi Thailam